Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Scott

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Clinical Transplantation|January 3, 2013
Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysisLinda L Wong, Willscott E Naugler, Jonathan Schwartz, et al.
Pharmacoeconomics|May 28, 2017
Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology AppraisalIñigo Bermejo, Matt Stevenson, Rachel Archer, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritisMonika Schoels, John Wong, David L Scott, et al.
Cancer Research|January 25, 2003
CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastomaAnthony D Sandler, Hiroshi Chihara, Gen Kobayashi, et al.
Rheumatology (Oxford, England)|September 1, 2014
Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysisVictoria L Manning, Billingsley Kaambwa, Julie Ratcliffe, et al.
The Journal of Rheumatology|September 3, 2018
Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical OutcomesKatie Bechman, Lieke Tweehuysen, Toby Garrood, et al.
Seminars in Arthritis and Rheumatism|June 30, 2014
The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysisFaith Matcham, Ian C Scott, Lauren Rayner, et al.
Rheumatology (Oxford, England)|March 11, 2016
Have radiographic progression rates in early rheumatoid arthritis changed? A systematic review and meta-analysis of long-term cohortsLewis Carpenter, Elena Nikiphorou, Rachel Sharpe, et al.
Pharmacoeconomics|March 17, 2018
Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology AppraisalLesley Uttley, Iñigo Bermejo, Shijie Ren, et al.
International Review of Psychiatry (Abingdon, England)|February 23, 2011
Comparative quality of life in patients with depression and rheumatoid arthritisHeidi Lempp, Fowzia Ibrahim, Tamara Shaw, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Clinical Transplantation|January 3, 2013
Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysisLinda L Wong, Willscott E Naugler, Jonathan Schwartz, et al.
Pharmacoeconomics|May 28, 2017
Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology AppraisalIñigo Bermejo, Matt Stevenson, Rachel Archer, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritisMonika Schoels, John Wong, David L Scott, et al.
Cancer Research|January 25, 2003
CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastomaAnthony D Sandler, Hiroshi Chihara, Gen Kobayashi, et al.
Rheumatology (Oxford, England)|September 1, 2014
Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysisVictoria L Manning, Billingsley Kaambwa, Julie Ratcliffe, et al.
The Journal of Rheumatology|September 3, 2018
Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical OutcomesKatie Bechman, Lieke Tweehuysen, Toby Garrood, et al.
Seminars in Arthritis and Rheumatism|June 30, 2014
The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysisFaith Matcham, Ian C Scott, Lauren Rayner, et al.
Rheumatology (Oxford, England)|March 11, 2016
Have radiographic progression rates in early rheumatoid arthritis changed? A systematic review and meta-analysis of long-term cohortsLewis Carpenter, Elena Nikiphorou, Rachel Sharpe, et al.
Pharmacoeconomics|March 17, 2018
Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology AppraisalLesley Uttley, Iñigo Bermejo, Shijie Ren, et al.
International Review of Psychiatry (Abingdon, England)|February 23, 2011
Comparative quality of life in patients with depression and rheumatoid arthritisHeidi Lempp, Fowzia Ibrahim, Tamara Shaw, et al.
Pageof 14